Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3657_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •Endovascular Aneurysm Repair
- •Clinical Applications
- •Aortic Procedures Planning
- •Performance Assessment
- •Future Prospects
- •References
- •References
- •Introduction
- •Medical Error
- •Traditional Training
- •Animal Simulation Labs
- •Virtual Reality Simulation
- •3: Radiation Safety
- •Introduction
- •Basic Radiation Physics Units
- •Personnel Dose Limits
- •Pregnant Personnel
- •References
- •4: Tools of the Trade
- •Needles, Catheters, and Wires
- •Vascular Access
- •Double Wall
- •Single Wall
- •Advantages/Disadvantages
- •Nonvascular Needles (Table 4.1)
- •Guidewires
- •Curved
- •Straight/Angled
- •Stiffness
- •Flexibility
- •Coating
- •Torqueability
- •Opacity
- •Catheters
- •Flush Catheters
- •Visceral Catheters
- •Multipurpose Catheters
- •Cerebral Catheters
- •Guiding Catheters
- •Microcatheters
- •Vascular Sheaths
- •Vessel Dilators
- •Accessories
- •Embolic Agents
- •Temporary Agents
- •Permanent Agents
- •Pushable Coils
- •Detachable Coils
- •Coiling Techniques (Fig. 4.48)
- •Vascular Plugs
- •Particulates
- •Liquid Embolics
- •Fogarty Balloons
- •Angioplasty Balloons
- •Drug-Coated Balloons
- •Vascular Stents
- •Balloon Expandable Stents
- •Self-Expandable Stents
- •Specialty Stents
- •References
- •Consults
- •Pre-procedure Evaluation
- •Consent
- •Code Status
- •Laboratory Testing
- •Antibiotic Prophylaxis
- •Anticoagulation
- •Antihypertensives
- •Contrast Allergy Prophylaxis
- •Procedure Plan
- •Post-procedure Management
- •Hospital Admission
- •Discharge
- •Follow-up Visits
- •IR Clinic
- •Conclusion
- •References
- •6: The IR Road Map: Vascular Anatomy Overview
- •Introduction
- •Imaging Modalities
- •Ultrasound
- •Computed Tomography
- •Magnetic Resonance Imaging
- •Cross-Sectional Anatomy
- •Chest
- •Segmental Lung Anatomy
- •Mediastinum
- •Pulmonary Arteries
- •Pulmonary Veins
- •Bronchial Arteries
- •Liver
- •Arterial Access
- •Double-Wall Technique
- •Common Femoral Artery Access
- •Kidneys
- •Ureters
- •Bladder
- •Uterus
- •References
- •Alternative Arterial Access Sites
- •Venous Access
- •Manual Compression
- •Closure Devices
- •Compression Devices
- •Topical Agents
- •Invasive Devices
- •References
- •9: Central Venous Access
- •Pathophysiology
- •Non-tunneled Central Catheters (NTCCs)
- •Tunneled Central Catheters (TCCs)
- •Implantable Ports
- •Peripherally Inserted Central Catheters (PICCs)
- •Clinical Indication
- •Conventional Therapy
- •Non-tunneled Central Catheters
- •Tunneled Central Catheters
- •Ports
- •PICCs
- •Interventional Therapy
- •Ports
- •PICCs
- •Pre-procedural Prep
- •History
- •Physical Exam
- •Imaging
- •Complex Venous Access
- •Post-procedural Management
- •Complications
- •Acute Complications
- •Long-Term Complications
- •Device Removal
- •Tunneled Catheter Removal
- •Port Removal
- •References
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •11: IVC Filters
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •IVC Filter Placement
- •VTE Prevention
- •Preprocedural Preparation
- •Complication
- •Access Site
- •Device-Related
- •Postprocedural Management
- •IVC Filter Retrieval
- •Advanced IVC Filter Retrieval Techniques
- •Conclusion
- •References
- •Pathophysiology
- •Arteriovenous Fistula
- •Arteriovenous Graft
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •AVG Angioplasty
- •AVF Angioplasty
- •References
- •13: Pelvic Congestion Syndrome
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •References
- •14: Varicocele
- •Pathophysiology
- •Conventional Therapy
- •Interventional Therapy
- •References
- •15: Varicose Veins
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •16: Vascular Malformations
- •Pathophysiology
- •Hemangiomas
- •Vascular Malformations
- •Arteriovenous Malformations (High Flow)
- •Venous Malformations (Low Flow)
- •Lymphatic Malformations
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •High-Flow AVMs
- •Low-Flow Venous Malformations
- •Klippel-Trenaunay Syndrome
- •Lymphatic Malformations
- •References
- •Pathophysiology
- •Abdominal Aortic Aneurysm (AAA)
- •Thoracic Aortic Aneurysm (TAA)
- •Clinical Indication
- •Abdominal Aortic Aneurysm
- •Thoracic Aortic Aneurysm
- •Conventional Therapy
- •Abdominal Aortic Aneurysm
- •Thoracic Aortic Aneurysm
- •Interventional Therapy
- •Abdominal Aortic Aneurysm
- •Thoracic Aortic Aneurysm
- •Common Complications
- •Access
- •Contrast Nephropathy
- •Spinal Cord Ischemia
- •Postoperative Monitoring
- •References
- •18: Aortic Dissection
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Preprocedure Work-Up
- •Post-procedural Management
- •References
- •19: Endoleak
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Type II Endoleaks
- •Type III Endoleaks
- •Type IV Endoleaks
- •Type V Endoleaks
- •References
- •20: Traumatic Aortic Injury
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Pre-procedural Prep
- •Pre-procedural Imaging
- •Post-procedural Management
- •Post-procedural Imaging
- •References
- •21: Bronchial Artery Embolization
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Outcomes
- •References
- •Pathophysiology
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •Clinical Indication
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •Conventional Therapy
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •Interventional Therapy
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •References
- •23: Lymphatic Interventions
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Pedal Lymphangiography (PL)
- •Intranodal Lymphangiography (IL)
- •Dynamic Contrast Enhanced MR Lymphangiography (DCMRL)
- •Thoracic Duct Embolization
- •Plastic Bronchitis
- •References
- •24: Mesenteric Ischemia
- •Pathophysiology
- •Acute Mesenteric Ischemia
- •Chronic Mesenteric Ischemia
- •Clinical Indication
- •Acute Mesenteric Ischemia
- •Arterial Occlusive Disease
- •Nonocclusive Mesenteric Ischemia (NOMI)
- •Portomesenteric Vein Thrombosis
- •Chronic Mesenteric Ischemia
- •Conventional Therapy
- •Acute Mesenteric Ischemia
- •Arterial Occlusive Disease
- •Nonocclusive Mesenteric Ischemia (NOMI)
- •Portomesenteric Vein Thrombosis
- •Chronic Mesenteric Ischemia
- •Interventional Therapy
- •Acute Mesenteric Ischemia
- •Chronic Mesenteric Ischemia
- •References
- •25: Visceral Aneurysms
- •Pathophysiology
- •Visceral Artery True Aneurysms (VATAs)
- •Visceral Artery Pseudoaneurysm (VAPA)
- •Clinical Indication
- •VATA
- •VAPA
- •Conventional Therapy
- •Interventional Therapy
- •Splenic Artery Aneurysms
- •Renal Artery Aneurysms
- •Hepatic Artery Aneurysms
- •Celiac Artery Aneurysms
- •Complications
- •Splenic Aneurysm
- •Renal Aneurysm
- •Hepatic Aneurysm
- •References
- •26: Renal Artery Stenosis
- •Pathophysiology
- •Clinical Indications
- •Conventional Therapy
- •Interventional Therapy
- •Post-procedural Care
- •Conclusion
- •References
- •27: GI Bleeding
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Complications
- •References
- •28: Uterine Artery Embolization
- •Pathophysiology
- •Fibroids
- •Adenomyosis
- •Postpartum Hemorrhage
- •Clinical Indication
- •Conventional Therapy
- •Fibroids
- •Adenomyosis
- •Postpartum Hemorrhage
- •Interventional Therapy
- •Fibroids
- •Adenomyosis
- •Postpartum Hemorrhage
- •AV Fistula
- •References
- •29: Prostate Artery Embolization
- •Pathophysiology
- •Benign Prostatic Hyperplasia
- •Prostate Cancer/Hematuria
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •30: Aortoiliac Disease
- •Pathophysiology
- •Blue Toe Syndrome
- •Leriche Syndrome
- •Fibromuscular Dysplasia
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Abdominal Aorta
- •Aortic Bifurcation
- •Common Iliac Artery
- •External Iliac Artery
- •Internal Iliac Artery
- •Blue Toe Syndrome
- •References
- •31: Infrainguinal Disease
- •Pathophysiology
- •Claudication (Rutherford Categories 1–3)
- •Critical Limb Ischemia: Rest Pain (Rutherford Category 4)
- •Critical Limb Ischemia: Skin Lesions (Rutherford Categories 5–6)
- •Acute Limb Ischemia
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Percutaneous Transluminal Angioplasty
- •Stents
- •Acute Limb Ischemia
- •References
- •Pathophysiology
- •Spleen
- •Liver
- •Kidney
- •Clinical Indication
- •Spleen
- •Liver
- •Kidney
- •Conventional Therapy
- •Spleen
- •Liver
- •Kidney
- •Interventional Therapy
- •Spleen
- •Pre-procedure
- •Post-procedure
- •Liver
- •Pre-procedure
- •Post-procedure
- •Kidney
- •Pre-procedure
- •Post-procedure
- •References
- •Pathophysiology
- •Pelvic Fractures
- •Extremity Fractures
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •34: Transarterial Chemoembolization
- •Pathophysiology
- •Clinical Indications
- •Conventional Therapy
- •Medical Management
- •Surgical Management
- •Interventional Therapy
- •Post-procedure
- •References
- •35: Transarterial Radioembolization (TARE)
- •Introduction
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Primary Liver Cancers
- •Hepatic Metastatic Disease
- •References
- •36: Liver Ablation
- •Pathophysiology
- •Liver Cancer
- •Liver Metastases
- •Liver Cysts
- •Clinical Indication
- •Conventional Therapy
- •Liver Cancer
- •Liver Metastases
- •Liver Cysts
- •Interventional Therapy
- •References
- •Pathophysiology
- •Lung Cancer
- •Renal Cell Carcinoma
- •Bone Lesions
- •Clinical Indication
- •Lung Cancer
- •Kidney Cancer
- •Bone Lesions
- •Conventional Therapy
- •Lung Cancer
- •Kidney Cancer
- •Bone Lesions
- •Interventional Therapy
- •Radiofrequency Ablation (RFA)
- •Microwave Ablation (MWA)
- •Cryoablation
- •Irreversible Electroporation (IRE)
- •Lung Cancer
- •Kidney Cancer
- •Bone Lesions
- •References
- •Pathophysiology
- •Conventional Therapy
- •Ascites
- •Varices
- •Interventional Therapy
- •References
- •Pathophysiology
- •Etiology
- •Clinical Indication
- •Conventional Therapy
- •Medical Management
- •Surgical Management
- •Interventional Therapy
- •Post-procedural Management
- •Complications
- •References
- •40: Biliary Drainage
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Conclusion
- •References
- •41: Biopsy Techniques
- •Introduction
- •Clinical Indication
- •Interventional Therapy
- •Needle Selection
- •Biopsy Techniques
- •References
- •Introduction
- •Pathophysiology
- •Ascites
- •Clinical Indication
- •Ascites
- •Conventional Therapy
- •Ascites
- •Interventional Therapy
- •Ascites
- •References
- •43: Obstructive Uropathy
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Urolithiasis
- •Infection
- •Urothelial Carcinoma
- •Neurogenic Bladder
- •Interventional Therapy
- •References
- •Pathophysiology
- •Clinical Indications
- •Percutaneous Radiologic Gastrojejunostomy (PRGJ) Tube
- •Percutaneous Jejunostomy (PJ) Tube
- •Conventional Therapy
- •Interventional Therapy
- •Percutaneous Radiologic Gastrostomy (PRG)
- •Post-procedural Management
- •Percutaneous Radiologic Gastrojejunostomy (PRGJ)
- •Percutaneous Jejunostomy (PJ)
- •References
- •45: Stroke
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Complications
- •Post-procedure Management
- •References
- •46: Cerebral Angiography: Aneurysms
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Pre-procedural Preparation
- •Post-procedural Management
- •Complications
- •References

Outer sheath fired: core
41 Biopsy Techniques
Fig. 41.10 Schematic
depicting how tissue is
obtained using core needle
biopsy
457
Core biopsy needle
Needle inserted into
mass
of tissue sampled
Needle removed with
core of tissue
Table 41.2 FNA vs. core biopsy: which to choose [10–12]
Advantages Disadvantages
FNA Lower complication
Core needle
biopsy
Key Point
rate
Smaller needle size
Increased exibility
Larger tissue sample
Increased accuracy
Smaller tissue sample
Requires presence of
cytopathologist to determine
sample adequacy
Larger needle size
Higher risk of complication
Single stick technique=biopsy device is inserted and
removed each time.
Coaxial technique = coaxial/trocar needle is left in
place and biopsy is performed through this needle
each time.
When performing an ultrasound biopsy, the interventionalist has the option of using a freehand technique or a needle
guide. With the freehand technique, the interventionalist
holds the ultrasound probe in one hand and the needle in the
other to allow maximum exibility. This allows both the
ultrasound and needle to be adjusted simultaneously in order
to adjust the trajectory of the needle and visualize the entire
shaft of the needle along its course. Depending on the anatomy, the ultrasound probe can be placed directly adjacent to
the needle or can be used in an off-axis way to utilize structures as acoustic windows to follow the path of the needle as
it traverses the tissues. This technique allows the physician
to have maximal movement of the needle, and as such, the
physician must deal with all the degrees of freedom during
movement of the needle.
Key Point
Freehand technique=no guide, maximum mobility.
Needle guide technique = device to guide needle,
decreases needle mobility.
The needle guide technique utilizes a guide attached to
the ultrasound probe such that the needle is aligned with the
long axis of the ultrasound probe (Fig.41.11). The track of
the needle path is usually displayed on the ultrasound monitor as a runway that the needle should follow (Fig.41.12).
Utilizing this guidance system allows for the physician to
negate many degrees of freedom and only have to account
for advancing the needle a certain distance to reach the
lesion. The downside of this technique is that the physician’s
ability to make adjustments in the path of the needle is
greatly reduced. The needle is locked into the positioning,
and the physician cannot independently move the probe separately from the needle to afford better visualization if
needed during the biopsy. Additionally, with breathing or
when traversing harder tissue planes, the needle can be
deected away from the projected course.
A simple supercial biopsy may not require sedation
and may only need to be performed with local anesthesia. For
more involved biopsies or deeper structures, moderate or
general anesthesia may be needed. Most pediatric biopsies are
performed with general anesthesia. As for all anesthesia cases,

458
the patient must be NPO for 6h to decrease the risk of aspiration.
In the outpatient setting, a patient must have a ride home if
receiving anesthesia. Appropriate laboratory parameters must
be checked prior to safely performing a procedure. This typically includes PT, PTT, INR, and platelets within 30 days
although exact timing is institutional dependent. Fibrinogen
can also be checked for patients with liver dysfunction.
Anticoagulant medications must be checked and held as
appropriate to decrease the risk of bleeding. Arrangements for
alternatives may need to be made in the interim.
S. Abay and A. B. Winick
The How To
1. ity, and patient status should be performed prior to
initiation of the procedure
2. The patient should be appropriately positioned and
scout imaging performed to ensure a safe route.
3. Anesthetize the tract under image guidance ensuring the pleural/peritoneal lining is adequately
anesthetized.
4. Place needle into lesion using image guidance. For
CT, this requires slowing advancing while checking
using the CT to ensure the needle is in the proper
trajectory.
5. Obtain biopsy using either single stick or coaxial
technique. Typically three to four biopsies are performed to obtain adequate samples for pathology
although this is institutional dependent.
6. For FNA biopsies the slides are created and analyzed
sampling. For core needle biopsies, the sample is
Fig. 41.11 Demonstration of a needle guide on the long axis of the
ultrasound probe. Note the limitation in operator movement of the
needle
Most biopsies can be performed as an outpatient with a
short recovery period following the procedure. More invasive procedures or those following anesthesia require a longer recovery time to monitor for complications and allow
recovery from sedation.
Fig. 41.12 (a) Focal liver biopsy with needle guide. A 52-year-old
male with history of carcinoid. Found to have new hepatic mass on
MRI. The lesion is seen here on ultrasound as a hypoechoic mass
(arrow). (b) Biopsy needle (arrow) is seen within the liver mass.
Pathological diagnosis was metastatic well-differentiated neuroendocrine tumor

41 Biopsy Techniques
459
Organ Specics
Nearly any organ in the body with the exception of the brain
can be biopsied percutaneously. Specic considerations are
warranted for each organ as they carry different risks and
benets (Table 41.3). Lung biopsies are frequently performed for determination of malignancy versus infection as
both can have similar imaging appearance and have increased
FDG uptake on PET-CT.Specic risks associated with lung
or pleural biopsies include the risk of a pneumothorax or
hemoptysis. There are several techniques that can be used to
decrease the risk of post-biopsy pneumothorax including
aspirating any obvious pneumothorax or administration of a
sealant into the tract during nal retraction of the needle to
seal the hole. If the patient develops an expanding pneumothorax or dyspnea related to the pneumothorax, a chest tube
may be warranted for treatment (refer to Chap. 42 for more
information), which requires inpatient admission.
A liver biopsy can be performed both percutaneously and
through the transjugular approach. Percutaneous can be
performed via the subcostal or intercostal approach depending
on liver positioning (see Fig.41.12). If intercostal approach
is chosen, all attempts should be made to avoid crossing the
pleural space to avoid a pneumothorax. The transjugular
approach is performed if the patient is at increased risk of
bleeding which cannot be corrected with medications or
infusions. Access is gained through the internal jugular vein
via the Seldinger technique and a catheter, and wire is
advanced into the hepatic veins, most commonly the middle
hepatic vein. Free and wedged pressures can be obtained to
determine the portal vein/hepatic vein pressure gradient.
Appropriate position is selected to ensure that adequate liver
parenchyma is present to avoid transgression of the liver capsule. A long biopsy needle is placed through the guide catheter and biopsy is performed (Fig. 41.13). Following the
biopsy, contrast can be injected to ensure there is no extravasation through the liver capsule. Possible complication following the transjugular approach includes renal injury if the
biopsy device inadvertently traverses the hepatic capsule
into the kidney.
Table 41.3 Organ-specic metrics for biopsies including success rate, complication rate, and indication for procedure
Organ Success rate Complications Indications
Lung 85% [15, 16] Pneumothorax
Liver 76% [17] Bleeding, pneumothorax, bile injury
Renal 95% [9] Bleeding, injury to urinary system
MSK 74–96% [9] Bleeding, fracture
Thyroid 84% [13] Bleeding
Lymph node
Pancreas 93–98% [10, 20] Bleeding
a
No data available
a
Coaxial 9–19%
FNA 27%
Hemoptysis
Coaxial 4–10%
FNA 2–5%
0–6% [9]
<2% [9]
<2% [9]
1–9% [14]
Bleeding
<1% [19]
1–8% [9]
Primary malignancy
Metastatic disease
Benign disease
Infection
Inammatory
Non-focal
Cirrhosis
Steatohepatitis
Hemochromatosis
Wilson’s disease
Focal
Primary malignancy
Metastatic disease
Benign disease
Non-focal
AKI
Chronic kidney disease
Focal
Primary malignancy
Benign disease
Primary malignancy
Benign mass
Infection (for culture, not diagnosis)
Primary malignancy [18]
Benign disease [18]
Recurrence s/p thyroidectomy [18]
Parathyroid mass
Primary malignancy
Reactive (infection/inammation)
Primary malignancy

460
Fig. 41.13 Transjugular liver
biopsy. Fluoroscopic image
shows an example of a transjugular liver biopsy. The long biopsy
needle (arrow) is within the liver
parenchyma, having been
advanced via the right internal
jugular vein
S. Abay and A. B. Winick
Fig. 41.14 (a) A 55-year-old female status post-liver transplantation
for HCC with increasing size of splenic lesion (red arrow). The FNA
biopsy needle can be seen just entering the splenic parenchyma. (b) Core
needle biopsy shows the needle traversing through the splenic lesion. (c)
Post-biopsy the patient endorses signicant abdominal pain and became
hypotensive. CTA demonstrates evidence of active extravasation (red
arrow) within the spleen with a large perisplenic hematoma. This tracked
down the left paracolic gutter and into the pelvis as well. Selective (d)
and supra-selective (e) splenic angiogram did not demonstrate any evidence of active extravasation. The mid- segmental splenic artery branch
was embolized empirically with Gelfoam. Final pathology was consistent with a hemangioma

41 Biopsy Techniques
Key Point
Remember, posteriorly the pleura ends at the 12th rib
and the lung at the 10th rib.
Key Point
Liver biopsy can be performed percutaneously or via a
transjugular approach. Risk of transjugular approach
includes renal injury.
One of the most common complications following any
biopsy is the risk of bleeding. Frequently bleeding is selflimited and requires no intervention. Occasionally, bleeding
can become life-threatening and require trans-arterial intervention for treatment (Fig.41.14).
Breast biopsies can be performed by ultrasound, mammography, or MRI guidance, typically by dedicated breast radiologists. This is used to differentiate benign from malignant
lesions. Prostate biopsies, typically performed by urologists,
can be targeted or nontargeted when a PSA is elevated or there
is a high clinical index of suspicion for malignancy.
With advances in imaging quality, availability, and tools,
image-guided biopsies have usurped surgical biopsies as a
minimally invasive option for obtaining tissue sampling. It
is not only less invasive, it is associated with fewer complications, a higher success rate, and is cost-effective.
References
1. Kaadan AN. Albucasis and thyroid surgery. Paper presented at:
39th international congress on the history of medicine, 2004; Bari,
Metaponto Italy.
2. Diamantis A, Magiorkinis E, Koutselini H. Fine-needle aspira-
tion (FNA) biopsy: historical aspects. Folia Histochem Cytobiol.
2009;47(2):191–7.
3. Webb AJ. Early microscopy: history of ne needle aspira-
tion (FNA) with particular reference to goiters. Cytopathology.
2001;12:1–6.
4. Rosa M. Fine-needle aspiration biopsy: a historical overview.
Diagn Cytopathol. 2008;36(11):773–5.
461
5. Farrell RJ, Smiddy PF, Pilkington RM, Tobin AA, Mooney EE,
Temperley IJ, et al. Guided versus blind liver biopsy for chronic
hepatitis C: clinical benets and costs. JHepatol. 1999;30(4):580–7.
6. Maya ID, Maddela P, Barker J, Allon M.Percutaneous renal biopsy:
comparison of blind and real-time ultrasound-guided technique.
Semin Dial. 2007;20(4):355–8.
7. Cesur M, Corapcioglu D, Bulut S, Gursoy A, Ender Yilmaz A,
Erdogan N, Kamel N. Thyroid. 2006;16(6):555–61. https://doi.
org/10.1089/thy.2006.16.555.
8. Watkinson A, Adam A. Interventional radiology: a practical
guide, vol. 42. NewYork: Radcliffe Medical Press; 1996. (ISBN 1
85775031 4)
9. Gervais DA, Sabharwal T, editors. Interventional radiology procedures in biopsy and drainage. London: Springer-Verlag London
Limited; 2001. (ISBN 978-1-84800-899-1)
10. Tyng CJ, Almeida MFA, Barbosa PN, Bitencourt AG, Berg JA,
Maciel MS, etal. Computed tomography-guided percutaneous core
needle biopsy in pancreatic tumor diagnosis. World JGastroenterol.
2015;21(12):3579–86.
11. Rotten D, Levaillant JM, Leridon H, Letessier A, Sandres
M.Ultrasonographically guided ne needle aspiration cytology and
core-needle biopsy in the diagnosis of breast tumors. Eur JObstet
Gynecol Reprod Biol. 1993;49:175–86.
12. Willems SM, van Deurzen CH, van Diest PJ. Diagnosis of breast
lesions: ne-needle aspiration cytology or core needle biopsy? A
review. JClin Pathol. 2012;65:287–92.
13. Choi SH, Han KH, Yoon JH, Moon HJ, Son EJ, Youk JH, etal.
Factors affecting inadequate sampling of ultrasound-guided neneedle aspiration biopsy of thyroid nodules. Clin Endocrinol.
2011;74(6):776–82.
14. Polyzos SA, Anastasilakis AD. Clinical complications following
thyroid ne-needle biopsy: a systematic review. Clin Endocrinol.
2009;71:157–65.
15. Khankan AA, Al-Muaikeel M.Image-guided percutaneous transthoracic biopsy in lung cancer--emphasis on CT-guided technique.
JInfect Public Health. 2012;5(Suppl 1):S22–30.
16. Otto S, Mensel B, Friedrich N, Schäfer S, Mahlke C, von Bernstorff
W, et al. Predictors of technical success and rate of complications
of image-guided percutaneous transthoracic lung needle biopsy of
pulmonary tumors. PLoS One. 2015;10(4):e0124947.
17. Fryer E, Wang LM, Verrill C, Fleming K. How often do our liver
core biopsies reach current denitions of adequacy? JClin Pathol.
2013–201440;66:1087–9.
18. Haugen BR, Alexander EK, et al. American Thyroid Association
management guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer. Thyroid. 2015;26(1):1–133. 2016.
https://doi.org/10.1089/thy.2015.0020.
19. Mueller M, Wittich G, Oeztuerk S, Kratzer W, Haenle M, Mason
R.Sonographically guided lymph node biopsy: complication rates.
Open JClin Diagn. 2012;2:30–5.
20. Zamboni GA, D'Onofrio M, Idili A, Malagò R, Iozzia R, Manfrin
E, Mucelli RP. Ultrasound-guided percutaneous ne-needle aspiration of 545 focal pancreatic lesions. AJR Am J Roentgenol.
2009;193(6):1691–5.

Ascites andPleural Effusion
KatherineSterner andArunKrishnaraj
Introduction
Ascites and pleural effusions are abnormal uid collections
within the peritoneal cavity and thoracic cavity, respectively.
Etiologies include underlying abnormalities in hydrostatic
and/or oncotic pressures, vascular permeability, or lymphatics. Treatment is aimed at the underlying cause. Initial diagnosis depends on clinical correlation with imaging ndings
and, oftentimes, uid sampling with percutaneous needle
drainage procedures including paracentesis and thoracentesis. Percutaneous image-guided procedures have become the
standard of care due to their cost-effectiveness and low
patient morbidity.
Pathophysiology
Ascites
42
blood volume activates the sympathetic nervous system
and renin- angiotensin- aldosterone system, which results
in increased sodium and water retention. In combination
with decreased plasma oncotic pressure due to hypoalbuminemia and increased portal pressures, excess uid accumulates in the peritoneal cavity [3, 4].
Key Point
The most common cause of ascites is cirrhosis.
Additional causes of ascites include obstructive, infectious, inammatory, traumatic, and malignant etiologies as
well as volume overload states as described in Table 42.1.
Accurate diagnosis is based on calculation of serum ascites
albumin gradient (SAAG) from a sample of ascites [5, 6].
Ascites is dened as an abnormal accumulation of uid
within the peritoneal cavity. Portal hypertension due to cirrhosis is the most common cause of ascites in the United
States, accounting for 85% of cases [1, 2]. The pathophysiology underlying cirrhotic ascites is multifactorial and not
completely understood. Currently, the most accepted theory proposes that hepatic sinusoidal hypertension results
in increased production of nitric oxide causing splanchnic
and peripheral vasodilation. Decreased effective arterial
Key Point
SAAG=serum albumin– ascites albumin.
SAAG <1.1 suggests a peritoneal cause of ascites.
SAAG >1.1 suggests a non-peritoneal cause of ascites
including portal hypertension.
Pleural Eusion
K. Sterner
University of Virginia Health System, Department of Radiology
and Medical Imaging, Charlottesville, VA, USA
e-mail: kls7qx@virginia.edu
A. Krishnaraj (
Division of Body Imaging, UVA School of Medicine, University of
Virginia Health System, Department of Radiology and Medical
Imaging, Charlottesville, VA, USA
e-mail: arunk@virginia.edu
© Springer International Publishing AG, part of Springer Nature 2018
N. A. Keefe et al. (eds.), IR Playbook, https://doi.org/10.1007/978-3-319-71300-7_42
*)
A pleural effusion is an abnormal accumulation of uid
within the pleural space. Approximately 2–5mL of physiologic pleural uid is normally present to function as a lubricant during respiration [1]. Excess pleural uid accumulates
in this space when there is an imbalance between uid production and clearance. Etiologies that induce uid imbalance
include increased hydrostatic forces, decreased oncotic pressure, increased capillary permeability, or obstructed or
463

464
Table 42.1 Etiologies of ascites [5]
Disease Pathophysiology
Budd-Chiari syndrome Hepatic venous outow tract obstruction:
Heart failure/renal
failure
Malignant ascites/
peritoneal
carcinomatosis
Nephrotic syndrome,
protein losing
enteropathy, severe
malnutrition
Chylous ascites Disruption of lymphatics due to trauma or
Pancreatic ascites Massive accumulation of pancreatic uid
Hemoperitoneum Traumatic due to accident, surgery, or
Tuberculous peritonitis Tuberculous implants on visceral and
Table 42.2 Etiologies of pleural effusion
Transudate Exudate
Congestive heart failure
Cirrhosis
Renal failure
Nephrotic syndrome Connective tissue disease
Hypoalbuminemia Pancreatitis
Pulmonary embolism Chylothorax
a
Most common etiologies
a
a
Thrombosis, phlebitis, or external
compression of suprahepatic IVC
Volume overload state causing increased
venous pressures and transudation of uid
Commonly seen in ovarian, breast, colon,
pancreas, and hepatocellular carcinomas.
The tumor cells seed the peritoneum and
produce excess uid in the peritoneal
cavity and/or obstruct lymphatics
Ascites results from hypoalbuminemia,
which decreases plasma oncotic pressure
resulting in third spacing of uid
obstruction as seen in malignancy
in the peritoneal cavity either due to
chronic pancreatitis, pancreatic pseudocyst
rupture, or traumatic injury
biopsy. Occasionally due to peritoneal
carcinomatosis causing bleeding
parietal peritoneum secrete proteinaceous
uid, similar mechanism to peritoneal
carcinomatosis
a
Parapneumonic effusion/exudate
Malignancy
Tuberculosis
Drug-induced
Esophageal rupture
Hemothorax
Empyema
a
a
K. Sterner and A. Krishnaraj
Key Point
New pleural effusions without denite cause or those
that fail conventional therapy require diagnostic
thoracentesis.
Congestive heart failure is the most common cause of a
transudative pleural effusion. Transudative effusions are
typically bilateral and often symmetric in size.
Parapneumonic effusions are the most common cause of
exudative effusions and occur as a complication of pneumonia. Three stages are described [11]:
• Stage 1: Exudative stage
– Simple parapneumonic effusion: Pulmonary inam-
mation resulting in increased vascular permeability of
visceral pleural. Effusions in this stage are small and
sterile.
• Stage 2: Fibropurulent stage
– Empyema: Pleural uid has become infected with
frank pus in the pleural space. The effusion is loculated
with thickened pleura.
• Stage 3: Organization stage
– Pleural peel or brothorax: Results from chronic
empyema and extensive pleural brosis. This causes
lung restriction and decreased lung volume, also
known as “trapped lung.”
Malignant pleural effusion, the second most common
cause of an exudative effusion, results from obstruction of
lymphatics by tumor cells and/or increased vascular permeability [10]. Malignant effusions are typically large and unilateral or bilateral and asymmetric as opposed to more
symmetric pleural effusions caused by congestive heart failure. Cancers that can metastasize to the pleura and cause
increased pleural uid production include lung, breast, genitourinary, and gastrointestinal cancers and lymphoma [10].
damaged lymphatics (Table42.2) [7]. Pleural effusions are
classied as either a transudate, where there is an imbalance
in hydrostatic forces or an exudate, characterized by
increased protein characteristic of underlying pleural disease
[7, 8]. This distinction is based on Light’s criteria where
pleural uid is classied as an exudate if one of the following
criteria is met [8–10]:
Pleural uid protein/serum protein >0.5
Pleural uid LDH/serum LDH >0.6
Pleural uid LDH >2/3 the upper limit of normal serum
LDH
Clinical Indication
Ascites
Indications to start treatment for ascites are based on patient
symptomatology including abdominal pain due to abdominal
distension, shortness of breath as a result from increased
abdominal girth and mass effect on the diaphragm, weight
gain, or anorexia [12]. Physical exam can reveal a distended
abdomen, bulging anks, a uid wave, or shifting dullness
[12]. Specic signs relating to etiology may also be present:

42 Ascites andPleural Eusion
465
• Liver disease: Palmar erythema, spider angiomata, and
caput medusa
• Malignancy
– Virchow node – left supraclavicular adenopathy as
seen in upper abdominal malignancy
– Sister Mary Joseph nodule – rm umbilical nodule;
suggests peritoneal carcinomatosis
• Heart failure: Increased jugular venous pressure, anasarca, or lower extremity edema which can also be seen in
renal disease
Ascites is graded on a 1+ to 4+ scale.
• 1+: Only detectable on careful physical examination
• 2+: Easily detectable, however small volume
• 3+: Large volume ascites, without a tense abdomen
• 4+: Large volume ascites with a tense abdomen
Imaging is obtained to assess the volume and characteristics of the uid present [13]. Ultrasound is the most costeffective means of assessing ascites, detecting as little as
10cc [12, 14]. Fluid typically collects in the most dependent regions in a supine patient: the hepatorenal recess
(Morrison’s pouch) in the abdomen or the rectouterine
pouch (pouch of Douglas) in the pelvis (Fig.42.1). Simple
uid is anechoic sonographically. Floating debris or septations can be seen in more complex or loculated collections,
respectively. On conventional radiography, ascites manifests as diffusely increased density or ground-glass opacity
of the abdomen with indistinct margins of the solid organs.
The anks may appear bulging and bowel loops will be
centralized (Fig.42.2). For these ndings to be conspicuous, at least 500mL of uid must be present [12, 15]. CT
is the most sensitive exam for detecting small amounts of
intraperitoneal uid and can also be useful in uncovering
Fig. 42.1 Ultrasound of the abdomen. (a) Transverse view through the
left hepatic lobe. Anechoic uid (ascites) surrounds the liver. (b) Longaxis view of the right kidney. Ascites is seen dependently within
Morrison’s pouch (arrow). (c) Ultrasound of the pelvis. Ascites is also
seen in the pelvis surrounding loops of bowel (arrows)

466
an underlying etiology (Fig. 42.3) [12, 13]. A nodular,
shrunken liver with sequela of portal hypertension such as
varices and splenomegaly are typical imaging ndings in
cirrhosis. Peritoneal nodules, omental caking, tumor, and
lymphadenopathy may be seen in malignancy. The uid
density can also be helpful in determining an etiology:
Hounseld units (HU) <20 suggest transudate, >20 exudate, and 45–65 hemoperitoneum.
Fig. 42.2 Conventional radiograph of the abdomen demonstrates dif-
fuse ground-glass opacity and centralization of bowel loops (arrows)
indicating ascites
K. Sterner and A. Krishnaraj
Key Point
CT is the most sensitive exam, while US is the most
cost-effective exam for detecting ascites. First-line
evaluation for ascites is by US.
Pleural Eusion
Symptoms of pleural effusions are nonspecic and include
cough, dyspnea, pleuritic chest pain, fever, night sweats,
and/or weight loss if secondary to malignancy. Physical
exam ndings include decreased breath sounds on auscultation, dullness to percussion, and decreased tactile fremitus if
a large volume is present, typically at least 300mL [16].
Chest radiographs are typically the initial diagnostic imaging
exam performed when a pleural effusion is suspected. On a
PA chest radiograph, 175mL of pleural uid must be present
to blunt the lateral costophrenic angles; 75mL is necessary
to blunt the posterior costophrenic angle, while a decubitus
view can detect as little as 10mL of pleural uid (Fig.42.4)
[7, 9, 11]. CT can detect very small volumes of uid and, as
with ascites, can aid in identifying the underlying lung
pathology [7, 10]. Simple effusions will appear as hypoattenuating dependent collections, measuring between 0 and
10 Hounseld units (HU) (Fig. 10.5 a, b); hemothorax will
have HU between 45 and 65 (Fig.42.5c). Loculated collections are nondependent and have a lenticular shape
(Fig.42.6). A parapneumonic effusion is a reactive simple
effusion with concomitant pneumonia (Fig.42.7). An empyema will demonstrate thickened and enhancing pleural,
Fig. 42.3 Contrast-enhanced axial CT through the upper abdomen. (a)
Ascites in the lower abdomen= surrounding loops of bowel (arrow).
The region of interest (ROI, as demarcated by the circle) demonstrates
Hounseld units of 9 consistent with simple uid. (b) Axial image
through the upper abdomen of a different patient demonstrating ascites
(solid arrow) and a shrunken, nodular liver (dotted arrow) consistent
with cirrhosis

42 Ascites andPleural Eusion
467
Fig. 42.4 Conventional radiographs of the chest. (a) PA chest radio-
graph demonstrates an opacity forming a meniscus in the right costophrenic angle, representing a small pleural effusion. (b) Same patient,
Fig. 42.5 Non-enhanced CT of the chest demonstrates a simple pleu-
ral effusion, left greater than right (solid arrows). The dotted arrow
points to partially collapsed lung
lateral view of the chest demonstrates a small right pleural effusion
(arrows). (c) PA chest radiograph of a different patient demonstrates a
large pleural effusion (arrow)
known as the split pleura sign (Fig.42.8) [10]. Ultrasound is
an additional imaging method to assess pleural effusion and
can detect as little as 20mL of pleural uid [17] (Fig.42.9a).
Ultrasound can further characterize effusions as complicated
by demonstrating debris, loculation, or septation (see
Fig.42.9b) [7, 9, 10].
Key Point
Decubitus radiograph is the most sensitive technique
for diagnosing a pleural effusion, detecting as little as
10cc.
Key Point
Empyemas must be drained either surgically or percu-
taneously in addition to appropriate antibiotic therapy.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
